Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Minoxidil in Breast Reconstruction
NCT07264790Phase 1Recruiting
- Sponsor
- Duke University
- Start
- Mar 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of minoxidil in Mastectomy skin flap necrosis (MSFN) (2 arms), sponsored by Duke University. Primary endpoints: Feasibility: Recruitment Rate at Day 1, Feasibility: Retention Rate at 90 days and 1 more. Started Mar 2026; status: recruiting.
02
Drugs
minoxidil
03
Conditions
Mastectomy skin flap necrosis (MSFN)
Beyond the preview
Go deeper on NCT07264790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07264790.